ACHP Letter to CMS on National Coverage Determination for Dementia Patients
ACHP submitted a letter to CMS about the National Coverage Determination for beta amyloid pet scans in dementia and neurodegenerative disease patients.
ACHP submitted a letter to CMS about the National Coverage Determination for beta amyloid pet scans in dementia and neurodegenerative disease patients.
ACHP submitted a letter to Congress in response to draft legislation with feedback on how to best serve dually eligible populations.
ACHP member organizations are committed to preventing and managing chronic disease – focusing on diabetes and hypertension – in communities across the nation.
ACHP represents the nation’s top-performing nonprofit health companies, which serve tens of millions of Americans in 37 states and D.C. ACHP member plans collaborate with providers on high-quality coverage and care — leading the industry in practical reforms.
ACHP joined a coalition in submitting comments in response to proposed rulemaking on substance use disorder patient records from HHS, OCR and SAMHSA.
ACHP is the voice of a unique approach in health care today, one that puts the patient at the center with plans and clinical teams collaborating to improve health outcomes and reduce costs. Our advocacy focuses on providing policymakers with tested solutions, rooted in a model that is proven to deliver better value for patients, employers and taxpayers.